Acquired by Firalis Group in 2012 and operating in two strategic locations—Huningue, France, in the heart of BioValley, and Cambridge, USA—Firalis Molecular Precision boasts a global team of 70+ experts.
Our professionals, with specialized knowledge and scientific expertise, understand your critical research needs and deliver tailored trial solutions across therapeutic areas like oncology, neurology, and cardiology.
Housed in a 5000 m² facility, Firalis Molecular Precision offers bioanalytical testing (multi-omics : genomics, proteomics, lipidomics, metabolomics), biobanking infrastructure, assay development, data analysis, and custom IVD kit production (CDMO) facilities.
At Firalis Molecular Precision, we stand as a steadfast partner, offering unwavering support to our clients throughout their drug development, clinical testing and biomarker discovery and monitoring journeys.
Every step of the way, we bring forth the right blend of cutting-edge technologies and specialized expertise to navigate the intricacies of these endeavors.
From disease biomarker discovery to drug/treatment development, trust us to be your reliable collaborator, ensuring success with precision and innovation at every crucial phase of your projects.
With a blend of passionate experts in multi-omics (genomics, proteomics, lipidomics and metabolomics), data science and business, we are dedicated in delivering the best results to our clients.
In fact, they are equipped with the knowledge, skills, and experience to utilize our cutting-edge technology efficiently, analyze collected data thoroughly and present solutions tailored to our clients’ specific needs.
They collaborate, innovate, and push boundaries to ensure that their work meets or exceeds standards.